- A progestin-only pill appropriate for nursing mothers
  • No negative side effects on breast-feeding1
  • No adverse effects on health, growth, or development of nursing infants1
- Appropriate for many patients who cannot tolerate estrogen
- Optimal packaging for ease of patient use
  • Compact enough to be carried in a purse
  • Available in familiar 28-day format
- Priced competitively to NOR-QD®
  • Check with your pharmacist

SAFETY INFORMATION
Women who use oral contraceptives (OCs) should be strongly advised not to smoke due to the increased risk of cardiovascular side effects. Serious risks reported with the use of OCs include blood clots, stroke, and heart attacks. OCs are contraindicated in women with thrombophlebitis, thromboembolic disorders, breast cancer, hepatic or estrogen-dependent neoplasia, cerebrovascular or coronary artery disease, jaundice, or undiagnosed genital bleeding. OCs do not protect against HIV infection (AIDS) or other sexually transmitted diseases.

Please see full Prescribing Information.
Reference: 1. Nora-BE full prescribing information.



Watson Pharmaceuticals, Inc.
Site Last Updated: 2006-06-23
This site is intended for US residents only. Copyright © 2003 - 2008 Watson Pharma, Inc. All rights reserved.
Terms of Use
Legal/Copyright Disclaimer Privacy Policy